Titration of antiserum to South American rattlesnake (Crotalus durissus terrificus) venom by measuring inhibition of phospholipase A2 activity.

The research describes the chemical interactions between the venom of the South American rattlesnake (Crotalus durissus terrificus) and its corresponding antiserum. The study suggests that the effectiveness of the antiserum could be standardized by measuring its ability to inhibit venom’s phospholipase A2 activity.

Introduction

The study is focused on determining the interactions between the venom of the South American rattlesnake (Crotalus durissus terrificus) and its corresponding antiserum. The antiserum is derived from a horse, specifically prepared to neutralize the venom of this specific species of rattlesnake. The main objective of the study is to provide a method for standardizing the potency of the antiserum using in-vitro techniques.

• The venom of the South American rattlesnake is known to have potent phospholipase A2 activity, which contributes to its toxicity.
• The antiserum to this venom is observed to inhibit the phospholipase activity of the venom, hinting at a possible correlation between the venom-neutralizing potential of the antiserum and its capability to inhibit the phospholipase A2 activity of the venom.

Experimental Design and Methodology

The researchers carried out experiments to identify and understand the close correlation between the antiserum’s ability to stop the phospholipase A2 activity within the venom and the antiserum’s ability to neutralize the venom.

• By observing the inhibition of phospholipase A2 activity, the effectiveness of the antiserum in neutralizing the venom’s toxicity could be estimated.
• The idea is to achieve a standardised and consistent method to measure the effectiveness of different batches of antiserum against the venom.

Findings and Implications

The research concludes a strong correlation between the antiserum’s inhibitory property and its neutralizing potency in vivo. This emphasizes that analysing the inhibitory properties of the antiserum could provide a foundation for a rigorous standardization process.

• Such a standardization method would increase the reliability of the antiserum, ensuring consistent potency and effectiveness across different batches.
• This would have practical implications in the manufacturing of antivenom for health and safety sectors dealing with venomous snakebite incidents, especially in regions where rattlesnakes are common.